Metenkefalin/Tridecactide

N/A

Report date: 2025/07/18 17:32:43

Base Information

Drug NameMetenkefalin/Tridecactide
Drug Alias NameEnkortenFAR-404EK-12
ClassificationSmall molecules
Mechanisms of ActionTh1 cells modulatorsδ-opioid receptor agonistsLeukocytes stimulants
Targetsδ-opioid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Multiple Sclerosis
Global Approved IndicationsMultiple Sclerosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryBosnia and Herzegovina
Original Approved Date2010/02/01
Country/TerritoryBosnia and Herzegovina
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesFarmacija
China Registration ClassN/A

Develop Information

Active CompaniesFarmacija
Inactive CompaniesBosnalijek D.D
Active IndicationsMultiple Sclerosis
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN07XX
Related LinksN/A